Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

749
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
749
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

516
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
516

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

Improving the clinical trial landscape for patients with atypical variants of Alzheimer's disease: a call to action.

Alzheimer's & dementia : the journal of the Alzheimer's Association·2026
Same author

Unilateral inferior olivary hypertrophy in a patient with primary progressive apraxia of speech.

Neuroimage. Reports·2026
Same author

Frontotemporal dementia: does structural MRI-based clustering match clinical syndromes?

Frontiers in neuroscience·2026
Same author

Advanced diffusion MRI tract signatures in Alzheimer's disease, dementia with Lewy bodies, and the FTD/PPA spectrum.

NeuroImage·2026
Same author

Biochemical and Immunohistochemical Associations of TDP-43 and Cryptic RNA With Hippocampal and Amygdala Volumetrics in Alzheimer's Disease.

Annals of neurology·2026
Same author

Comparative effects of TDP-43-A and TDP-43-α on hippocampal subfields and amygdala nuclei.

Journal of Alzheimer's disease : JAD·2026

相关实验视频

Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K

生物标志物 生物标志物

Jennifer L Whitwell1

  • 1Mayo Clinic, Rochester, MN, USA.

Alzheimer's & dementia : the journal of the Alzheimer's Association
|December 24, 2025
PubMed
概括
此摘要是机器生成的。

神经成像生物标志物显示出跟踪阿尔茨海默病 (AD) 在非典型形式的进展的前景. 了解缩模式和陶沉积对于优化不同AD患者群体的临床试验至关重要.

更多相关视频

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

相关实验视频

Last Updated: Jan 7, 2026

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies
07:20

Dried Blood Spot Collection of Health Biomarkers to Maximize Participation in Population Studies

Published on: January 28, 2014

37.1K
Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances
07:35

Selecting Multiple Biomarker Subsets with Similarly Effective Binary Classification Performances

Published on: October 11, 2018

7.9K
Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans
08:14

Ecotoxicological Methodologies to Evaluate Biomarkers at Different Scales in Neotropical Anurans

Published on: April 28, 2023

702

科学领域:

  • 神经科学是一个神经科学.
  • 医疗成像医学成像
  • 神经学 神经学

背景情况:

  • 神经成像技术评估阿尔茨海默病 (AD) 中的大脑结构,功能和蛋白质沉积.
  • 虽然对amnestic AD的研究是广泛的,但非典型的AD表现 (语言,视觉,dysexecutive,行为,运动) 需要进一步调查临床试验.
  • 非典型的AD患者,通常更年轻,具有较少的共同病理,为研究疾病进展和治疗效应提供了更纯粹的模型.

研究的目的:

  • 评估神经成像生物标志物的实用性,以评估非典型阿尔茨海默病 (AD) 变体中的疾病进展.
  • 确定最佳的神经成像指标和样本大小,以检测语言和视觉AD的临床试验中的治疗效果.
  • 探索tau PET成像和连接指标作为非典型AD的结果指标的潜力.

主要方法:

  • 分析大脑缩率,专注于皮质测量,语言和视觉AD表型.
  • 根据下缩率,估计检测20%治疗效果所需的样本大小.
  • 使用PET成像评估tau沉积模式,并评估默认模式网络连接变化.

主要成果:

  • 皮质缩测量对于非典型的AD来说比中间时测量更有效.
  • 检测治疗效应的样本大小估计为113名语言AD患者和100名视觉AD患者 (每只手臂),基于下缩.
  • 的吸收模式在非典型的AD表型中相对一致,但速度不同,可能会限制晚期疾病的实用性. 连接性下降,特别是在默认模式网络中,显示出受年龄和tau负担影响的变化.

结论:

  • 神经成像生物标志物,包括缩率和陶沉积,对于监测非典型阿尔茨海默病的疾病进展是有价值的.
  • 在设计非典型AD的临床试验时,必须考虑缩模式,年龄和疾病阶段的异质性.
  • 需要进一步的研究,以确定最佳的生物标志物,以跟踪阿尔茨海默氏病的整个频谱的疾病进展.